The applied value of public investments in biomedical research
Author(s)
Li, Danielle; Sampat, Bhaven N.; Azoulay, Pierre
DownloadnewBasic-Applied_3-17-2017-Pierre-Azoulay.pdf (804.0Kb)
PUBLISHER_POLICY
Publisher Policy
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Terms of use
Metadata
Show full item recordAbstract
Scientists and policy-makers have long argued that public investments in science have practical applications. Using data on patents linked to U.S. National Institutes of Health (NIH) grants over a 27-year period, we provide a large-scale accounting of linkages between public research investments and subsequent patenting. We find that about 10% of NIH grants generate a patent directly but 30% generate articles that are subsequently cited by patents. Although policy-makers often focus on direct patenting by academic scientists, the bulk of the effect of NIH research on patenting appears to be indirect. We also find no systematic relationship between the “basic” versus “applied” research focus of a grant and its propensity to be cited by a patent.
Date issued
2017-03Department
Sloan School of ManagementJournal
Science
Publisher
American Association for the Advancement of Science (AAAS)
Citation
Li, Danielle, Pierre Azoulay, and Bhaven N. Sampat. “The Applied Value of Public Investments in Biomedical Research.” Science 356, no. 6333 (March 30, 2017): 78–81. © 2017 American Association for the Advancement of Science (AAAS)
Version: Author's final manuscript
ISSN
0036-8075
1095-9203